Silence Therapeutics (SLN) EBITDA (2024 - 2026)
Silence Therapeutics (SLN) reported EBITDA of -$15.7 million for Q1 2026, up 44.61% on a YoY basis from -$10.9 million in Q1 2025, and down 26.29% sequentially from -$12.5 million in Q4 2025.
Silence Therapeutics (SLN) EBITDA (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of EBITDA data on file, last reported at -$15.7 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 44.61% year-over-year to -$15.7 million; the trailing twelve-month figure through Mar 2026 stood at -$78.4 million (up 8.99% YoY), and the FY2025 full-year result was -$91.1 million, down 43.84% from the prior year.
- EBITDA retreated to -$15.7 million in Q1 2026, from -$12.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$4.4 million in Q4 2024 to a low of -$30.0 million in Q3 2024.
- A 3-year average of -$18.9 million and a median of -$23.4 million in 2024 frame the typical range for EBITDA.
- Across the five-year window, EBITDA slumped 409.03% in 2025 and jumped 44.61% in 2026, its largest moves.
- Tracing SLN's EBITDA over 3 years: stood at -$4.4 million in 2024, then plunged by 186.33% to -$12.5 million in 2025, then dropped by 26.29% to -$15.7 million in 2026.
- Business Quant data shows SLN's EBITDA at -$15.7 million in Q1 2026, -$12.5 million in Q4 2025, and -$26.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -15.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.74 Mn |
| Dec 31, 2025 | -12.46 Mn |
| Sep 30, 2025 | -26.24 Mn |
| Jun 30, 2025 | -23.96 Mn |
| Mar 31, 2025 | -28.41 Mn |
| Dec 31, 2024 | -4.35 Mn |
| Sep 30, 2024 | -30.00 Mn |
| Jun 30, 2024 | -23.39 Mn |
| Mar 31, 2024 | -5.58 Mn |